A recent communication has been released regarding the memorial service for the late Neil Frick, a cherished colleague whose passing has deeply affected the National Bleeding Disorders Foundation (NBDF) and the bleeding disorders community.Neil…
On October 11, 2024, Pfizer announced that the U.S. FDA approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric individuals 12 years of age and older with…
Speaker: Lindsey A. George, MD Are you or a loved one affected by hemophilia A? Curious about cutting-edge treatments that could change lives? Join us for an exciting webinar where Dr. Lindsey A. George will shed…
Speakers:Katherine Bush, LCSW at the Hemophilia Center of Western Pennsylvania Shanna Garcia, Director of Development, Texas Central Bleeding DisordersSupporting Your Teen’s Mental Health: Key Strategies for Parents…
October HANDI Highlights is dedicated to an historically underserved group within the inherited bleeding disorders community - women, girls, and people with the propensity to menstruate (WGPPM). While awareness of these populations has increased in…
The National Bleeding Disorders Foundation (NBDF) is pleased to announce that Evan Schow of Bigfork, Montana, was selected as the recipient of the 2024 Kevin Child Scholarship (KCS). The Child family selected Evan as this year’s KCS…
Authors: J Nicole Clark (1), Sarah Dunn (2,3), Lora Joyner (4), Anne Gonzales (5)University of Colorado Hemophilia and Thrombosis Center Penn Comprehensive Hemophilia and Thrombosis Program Good Shepherd Penn Partners at Penn Presbyterian…
Evan Schow was selected as the recipient of the 2024 Kevin Child Scholarship (KCS). He is a pre-med freshman studying microbiology at Brigham Young University in Provo, Utah. He has worked as a counselor at Camp Valor Hemophilia Camp, participated…